Toboroz
Personalising Treatment for Myeloma Patients Based on Initial Response to NHS Treatment and Their Overall Fitness Level
NCT07649525· 3. fázis· University of Leeds· Forrás
Contact: Sally Moore, Dr
Toboroz
DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers.
NCT07440290· 2/3. fázis· Cancer Research UK· Forrás
Contact: Antony Ng, Dr
Toboroz
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
NCT07284849· 3. fázis· Incyte Corporation· Forrás
Toboroz
Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)
NCT07053800· 2. fázis· Autolus Limited· Forrás
Contact: Autolus Ltd
Toboroz
DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young Adult Patients With ROS1 Gene Fusion-Positive Cancers.
NCT05770544· 2/3. fázis· Cancer Research UK· Forrás
Contact: Antony Ng, Dr
Toboroz
A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia
NCT06721013· 1/2. fázis· Eli Lilly and Company· Forrás
Toboroz
A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer
NCT06340568· 3. fázis· BioNTech SE· Forrás
Toboroz
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
NCT06892548· 1/2. fázis· BioNTech SE· Forrás
Toboroz
A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
NCT06585774· 3. fázis· Incyte Corporation· Forrás
Toboroz
DETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET Dysregulations
NCT06988475· 2/3. fázis· Cancer Research UK· Forrás
Contact: Antony Ng, Dr
Toboroz
A Study of MOv18 IgE in Patients With Solid Tumours That Express Folate Receptor Alpha
NCT06547840· 1. fázis· Epsilogen Ltd· Forrás
Contact: Epsilogen Clinical Trials
Toboroz
Personalized Medicine for Advanced Biliary Cancer Patients
NCT05615818· 3. fázis· UNICANCER· Forrás
Contact: Stephen FALK, MD
Fut, nem toboroz
A Study Comparing Niraparib With Temozolomide in Adult Participants With Newly-diagnosed, MGMT Unmethylated Glioblastoma
NCT06388733· 3. fázis· Ivy Brain Tumor Center· Forrás
Fut, nem toboroz
Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)
NCT06225596· 2. fázis· BicycleTx Limited· Forrás
Toboroz
DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive Cancers
NCT05770037· 2/3. fázis· Cancer Research UK· Forrás
Contact: Antony Ng, Dr
Toboroz
DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition
NCT05770102· 2/3. fázis· Cancer Research UK· Forrás
Contact: Antony Ng, Dr
Toboroz
DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating Mutations
NCT05786716· 2/3. fázis· Cancer Research UK· Forrás
Contact: Antony Ng, Dr
Toboroz
DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers.
NCT05768178· 2/3. fázis· Cancer Research UK· Forrás
Contact: Antony Ng, Dr
Toboroz
DETERMINE (Determining Extended Therapeutic Indications for Existing Drugs in Rare Molecularly Defined Indications Using a National Evaluation Platform Trial) - Master Screening Protocol
NCT05722886· 2/3. fázis· Cancer Research UK· Forrás
Contact: Antony Ng, Dr
Toboroz
A Trial of 5 Fraction Prostate SBRT Versus 5 Fraction Prostate and Pelvic Nodal SBRT
NCT05613023· 3. fázis· Institute of Cancer Research, United Kingdom· Forrás
Contact: Thomas Bird
Toboroz
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
NCT05254743· 3. fázis· Loxo Oncology, Inc.· Forrás
Contact: Sanne Lugthart (principal investigator)
Toboroz
A Randomised Open-label Phase III Trial of REduced Frequency Pembrolizumab immuNothErapy for First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC)
NCT05085028· 3. fázis· Imperial College London· Forrás
Contact: Adam Dangoor
Toboroz
Brentuximab Vedotin in Early Stage Hodgkin Lymphoma
NCT04685616· 3. fázis· University College, London· Forrás
Contact: Claire Burney
Fut, nem toboroz
Effectiveness of the SpaceOAR Vue System in Subjects With Prostate Cancer
NCT04905069· Boston Scientific Corporation· Forrás
Fut, nem toboroz
A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers
NCT05152147· 3. fázis· Jazz Pharmaceuticals· Forrás
Toboroz
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
NCT05020236· 3. fázis· Pfizer· Forrás
Fut, nem toboroz
A Phase 3 Study to Assess Efficacy and Safety of Tafasitamab Plus Lenalidomide and Rituximab Compared to Placebo Plus Lenalidomide and Rituximab in Patients With Relapsed/Refractory (R/R) Follicular Lymphoma or Marginal Zone Lymphoma.
NCT04680052· 3. fázis· Incyte Corporation· Forrás
Toboroz
Methods of T Cell Depletion Trial (MoTD)
NCT04888741· 2. fázis· University of Birmingham· Forrás
Contact: MoTD Trial
Fut, nem toboroz
A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-MutatedProstatic Neoplasms (mCSPC)
NCT04497844· 3. fázis· Janssen Research & Development, LLC· Forrás
Toboroz
FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma
NCT04625907· 1/2. fázis· University of Birmingham· Forrás
Contact: Helen Rees
Fut, nem toboroz
A Study Comparing JNJ-68284528, a CAR-T Therapy Directed Against B-cell Maturation Antigen (BCMA), Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) or Daratumumab, Pomalidomide and Dexamethasone (DPd) in Participants With Relapsed and Lenalidomide-Refractory Multiple Myeloma
NCT04181827· 3. fázis· Janssen Research & Development, LLC· Forrás
Fut, nem toboroz
Study to Evaluate the Efficacy and Safety of Lutathera in Patients With Grade 2 and Grade 3 Advanced GEP-NET
NCT03972488· 3. fázis· Advanced Accelerator Applications· Forrás
Fut, nem toboroz
An Extension Study of IMR-687 in Adult Patients With Sickle Cell Anemia
NCT04053803· 2. fázis· Imara, Inc.· Forrás
Toboroz
Renal Adjuvant MultiPle Arm Randomised Trial
NCT03288532· 3. fázis· University College, London· Forrás
Contact: Amit Bahl (principal investigator)
Fut, nem toboroz
Stereotactic Body Radiotherapy for the Treatment of OPD
NCT03256981· 2/3. fázis· Institute of Cancer Research, United Kingdom· Forrás
Fut, nem toboroz
CompARE: Escalating Treatment of Intermediate and High-risk Oropharyngeal Cancer (OPC)
NCT04116047· 3. fázis· University of Birmingham· Forrás
Fut, nem toboroz
Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Standard of Care After Curative Intent Resection of Biliary Tract Cancer
NCT02170090· 3. fázis· Universitätsklinikum Hamburg-Eppendorf· Forrás
Fut, nem toboroz
Prostate Advances in Comparative Evidence
NCT01584258· 3. fázis· Royal Marsden NHS Foundation Trust· Forrás
Fut, nem toboroz
Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy
NCT00268476· 2/3. fázis· Medical Research Council· Forrás